Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization - sprookjes - yvandenbroek - TriplyDB

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

http://www.wikidata.org/entity/Q24599495

about

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens Gene vaccination with naked plasmid DNA: mechanism of CTL priming Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice Th1/Th2 cells Immunological mechanisms of allergen-specific immunotherapy Type I interferon is required to mount an adaptive response to immunostimulatory DNA Intrinsic properties of allergens and environmental exposure as determinants of allergenicity.Recombinant mite allergens. New technologies for the management of patients with asthma.Various factors (allergen nature, mouse strain, CpG/recombinant protein expressed) influence the immune response elicited by genetic immunization.Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.Deviation of the allergic IgE to an IgG response by gene immunotherapy.Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.The dichotomy of pathogens and allergens in vaccination approaches Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria.Activation of skin dendritic cells by immunostimulatory DNA.The response of human B lymphocytes to oligodeoxynucleotides.Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae Advances in skin gene therapy.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'.DNA-based vaccination for the treatment of food allergy.Immunostimulatory DNA-based therapeutics for experimental and clinical allergy.Antigen-based immune modulation: DNA vectors and beyond.C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis Microbial products in allergy prevention and therapy.DNA vaccines for non-infectious diseases: new treatments for tumour and allergy.DNA-based vaccines for allergic disease.T cell activation, from atopy to asthma: more a paradox than a paradigm.Actual therapeutic management of allergic and hyperreactive nasal disorders Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation.Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.DNA vaccines for poultry: the jump from theory to practice.

P2860

Q24302386-2FCD19F8-D693-46B2-9273-23586DBBC224 Q24514954-37BFAC8A-D50A-4601-AEE0-6520090E8E84 Q24644853-34F98571-D7AC-4B35-B8E1-6EB302886081 Q24673500-2A3BAF2B-AE4E-4005-945B-87DD08DC6983 Q24676957-DC40564A-9189-4FCF-A66C-8E330EF6F05B Q25257883-5F90754C-60FB-4979-9460-BEBE4F25B491 Q27469552-07F594BF-1CF1-4891-964A-3D8475013A86 Q27469642-86232F71-B4BF-41FE-852D-DCB408BA9999 Q28138975-DBFEFFA7-E02C-44F5-9A9D-885ED7489E25 Q28265326-0008B24B-A3B5-4475-8C9D-157DD97CCDF5 Q28508204-EE63D3DF-C17E-4E3B-98F1-2DE754DB4ED6 Q30309644-A0BCCA9B-4BCD-4BAE-8D1E-50A4254224BF Q30470634-EBA5FC35-C901-4247-89BB-838630B59855 Q30951642-1AC7677E-19D8-4475-8A2F-D9780E8D96DF Q32140773-DB7161D3-7690-4191-AD54-A7FBE97A5F9D Q33645053-B0150B10-D707-48AE-829B-E2B73042596A Q33767207-D00A86E6-3369-4DE8-B20C-128ABF0FA116 Q33784968-D6FBC865-8D21-419E-B3F9-0198566490CC Q33805880-BC2A236D-0677-495E-8865-0B2FEE27DE40 Q33835115-8834E3A6-39DA-44EC-BB80-DC267994AF87 Q33909251-729EBB44-D396-494D-BE8A-632B43037837 Q34001352-D98B0053-3682-4E2E-A473-7A9AEE77513B Q34002662-BF665955-52FD-4848-BBE5-92340848BF9D Q34005392-D6524FEC-4572-4F2F-97B0-C58BB2A16D82 Q34005403-83690D1C-3E98-4D3D-B17A-DCD1F79AC5B1 Q34008890-F2F969EA-7B35-4231-BBCD-1FF18D58870A Q34075060-3D923735-7937-4FEC-8F69-813524323D1E Q34111856-7883B821-5892-4401-B9EB-A8156A61782E Q34216121-39AFD84E-0319-4EA4-A7E2-584F911D48CA Q34764668-BB19DFA8-0F16-4F13-BD98-8FB4F89B65D4 Q35040861-A9A416CD-EF2E-4DB1-AA7D-017067E71A70 Q35126948-DB113646-F264-40F5-801F-0F00E6E520F6 Q35131619-CB0F2AF3-181B-4678-927D-2F65E7E0BC39 Q35164804-8F1B1789-EDCC-45B3-97D8-1A3FAAEBDC0C Q35193425-9DE9F1FE-2F0B-4956-8F23-73A3B653E642 Q35197012-56365F0F-2167-48E6-BDB2-9BB9D3EA21A9 Q35427205-C90097AE-9A7D-4FFC-8F72-327FCF7AB261 Q35427832-535E42BC-1E81-498C-8B01-11C634B1EBC0 Q35896155-32551DC4-062D-4078-94A7-E26CD190AAE6 Q36066247-8000AE06-2482-4CB2-8248-B90667697830

P2860

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

http://www.wikidata.org/entity/Q24599495

description

1996 nî lūn-bûn

@nan

1996 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Preferential induction of a Th ...... on by plasmid DNA immunization

@ast

Preferential induction of a Th ...... on by plasmid DNA immunization

@en

Preferential induction of a Th ...... on by plasmid DNA immunization

@nl

type

label

Preferential induction of a Th ...... on by plasmid DNA immunization

@ast

Preferential induction of a Th ...... on by plasmid DNA immunization

@en

Preferential induction of a Th ...... on by plasmid DNA immunization

@nl

prefLabel

Preferential induction of a Th ...... on by plasmid DNA immunization

@ast

Preferential induction of a Th ...... on by plasmid DNA immunization

@en

Preferential induction of a Th ...... on by plasmid DNA immunization

@nl

P1433

Q24599495-EE474ACC-7CA2-4605-8497-D05383A0B018

P1476

Q24599495-7BC1B6BB-CA1A-4EB1-A7D2-55D543108859

P2093

Q24599495-3947412C-FCE2-4028-9469-2F0763DF6B68

Q24599495-3C350C35-BF74-428E-B8DD-BBA974D76EFE

Q24599495-4FBB32DC-4196-4F93-9E66-F4594E3220D8

Q24599495-6EE7EC54-3509-4935-BE52-354705615DA4

Q24599495-8602FCBF-1C7C-4F10-A94C-2A89C5836F04

Q24599495-B70DF650-F153-4287-906E-AE97A86D162C

Q24599495-BF16274D-D119-4698-987A-323F3BA077B9

Q24599495-C5EA2AB3-4341-4CB5-A1C0-8681AA6D571D

Q24599495-E82CB84A-3FE9-489C-9B14-E46C82E43162

P2860

Q24599495-0F876347-304A-424E-8C6B-05BB932EABDD

Q24599495-195C9EE3-CE02-41E2-91C0-BED0C610F98A

Q24599495-217FF3CD-21C7-4FA3-9CAA-8C2FB95B029A

Q24599495-2D907031-AD8A-4119-BF0F-3796AF0B2444

Q24599495-2ED39D17-59B4-489B-8E4E-EE55DF87A46C

Q24599495-33391F13-25F7-475B-A7AC-4484BD20CADC

Q24599495-3A3739D8-0EDA-4079-BE2C-BF4A830845B1

Q24599495-3E7ADBCB-0C8E-4D81-AB1B-1682B7C27EC0

Q24599495-4638980D-8C0D-4643-889E-DA9E917E2DAC

Q24599495-67382268-2F87-43A8-AECB-E038605D34D1

P304

Q24599495-81AB1586-8C9B-4D0C-90DD-28E157F6A704

P31

Q24599495-DDD16849-A295-40EE-AB14-40B41B4187BE

P356

Q24599495-E5DFBD9F-62EE-4FA6-841F-F1E9EFFA5D10

P407

Q24599495-7FA6A394-E061-40BB-9604-259E863E6ECA

P433

Q24599495-4739EB29-0BB6-4DBF-9EAB-59D8D906B7C6

P478

Q24599495-068E860B-0DF2-4888-97EF-463851D7A0A7

P577

Q24599495-45E7E99B-34ED-450D-8136-022766C8899A

P5875

Q24599495-3CBA754F-565B-4CDE-AED9-9F826AADB340

P698

Q24599495-5D8FEC38-8601-410A-94AC-DD290BEB8995

P921

Q24599495-44E456A1-97CF-47E5-9738-96720BFF47C4

Q24599495-5E80541C-3B99-402B-9D54-F76ACB24918D

P932

Q24599495-6E3865CE-64E4-4C2A-A7CF-7E01A964A2D9

P356

PNAS.93.10.5141

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Preferential induction of a Th ...... on by plasmid DNA immunization

@en

P2093

D A Carson

http://www.w3.org/2001/XMLSchema#string

E Raz

http://www.w3.org/2001/XMLSchema#string

H L Spiegelberg

http://www.w3.org/2001/XMLSchema#string

H Tighe

http://www.w3.org/2001/XMLSchema#string

J A Dudler

http://www.w3.org/2001/XMLSchema#string

M Corr

http://www.w3.org/2001/XMLSchema#string

M Roman

http://www.w3.org/2001/XMLSchema#string

S L Swain

http://www.w3.org/2001/XMLSchema#string

Y Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma

IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

Regulation of immunity to parasites by T cells and T cell-derived cytokines.

Gene inoculation generates immune responses against human immunodeficiency virus type 1

Virally induced modulation of murine IgG antibody subclasses.

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.

P304

5141-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.10.5141

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14556106

http://www.w3.org/2001/XMLSchema#string

P698

8643542

http://www.w3.org/2001/XMLSchema#string

P921

P932

39421

http://www.w3.org/2001/XMLSchema#string